Rapport Therapeutics (RAPP) Change in Receivables (2026)
Rapport Therapeutics' (RAPP) quarterly Change in Receivables came in at $58000.0 in Q1 2026.
Rapport Therapeutics (RAPP) Change in Receivables (2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 1 years of Change in Receivables data on file, last reported at $58000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rapport Therapeutics | 1.95 Bn | 1.95 Bn | - | 58,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,000.00 |
| Mar 31, 2026 | 58,000.00 |